Floatz logo

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril

Stenosis Artery

Asan Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Stenosis Artery cohort.

Asset / SponsorPhaseRating
Plavix
Asan Medical Center
Phase 4BB
Lipitor
Columbia University
Phase 4BB
EPHEDRINE, ANHYDROUS
University Hospital, Clermont-Ferrand
Phase 4BB
Acetylsalicylic Acid
Asan Medical Center
Phase 4BB
AMLODIPINE
Russian Cardiology Research and Production Center
Phase 4BB

View all 27 →

Same molecule, other indications

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril is also rated in:

cerebral infarctionDormant
BBB
Indicative ·
79 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
75 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →